Deverra Therapeutics Email Format

Biotechnology ResearchWashington, United States2-10 Employees

Deverra Therapeutics is a Seattle-based biotechnology company focused on developing allogeneic, off-the-shelf cellular immunotherapies intended for on-demand treatment of cancer and infectious diseases. Its work centers on leveraging a proprietary stem cell expansion and directed-differentiation platform licensed from the Fred Hutchinson Cancer Research Center, enabling the generation of various unmodified and modified immune cell types for therapeutic use. The company operates within the biotechnology research sector, aiming to provide cellular immunotherapy options that can be readily available to patients. Based in Seattle, Washington, Deverra is described as a clinical-stage enterprise working to advance immuno-oncology and infectious disease therapies, with its activities rooted in a substantial program of federally funded research and clinical data accumulated over more than two decades. A notable recent development involves related corporate activity and recognition within the life sciences community, reflecting ongoing progress in its field.

Get verified Deverra Therapeutics emails free

Company overview Employee directory